Article: Somaxon's SILENOR(TM) Demonstrates Positive Results in Long-Term Phase 3 Clinical Trial in Elderly Patients with Insomnia.

Article: Somaxon Pharmaceuticals' SILENOR(TM) Demonstrates Positive ...
PR Newswire;  November 20, 2006 ;     700+ words ... ... company's Phase 3 clinical trial evaluating SILENOR(TM) (doxepin HCl ... its second Phase 3 clinical trial, which evaluated SILENOR(TM) in healthy adults ... its remaining Phase 3 clinical trial for SILENOR(TM) in December ...

Article: Somaxon Pharmaceuticals' SILENOR(TM) Demonstrates Positive ...
PR Newswire;  October 23, 2006 ;     700+ words ... ... Represents Second Phase 3 Clinical Trial of SILENOR(TM) to Demonstrate ... the company's Phase 3 clinical trial evaluating SILENOR(TM) (doxepin HCl ... trial. This is the first clinical trial for SILENOR(TM) that we specifically ...

Article: Somaxon Pharmaceuticals, Inc. Initiates Second Phase III ...
Business Wire;  September 20, 2005 ;     700+ words ... ... second Phase III clinical trial of SILENOR(TM) (doxepin ... controlled Phase III clinical trial will evaluate ... and efficacy of SILENOR(TM) over a ... and efficacy of SILENOR(TM) in this Phase III clinical trial in the elderly ...

Article: Somaxon Pharmaceuticals to Announce Results of Phase 3 ...
Business Wire;  December 17, 2006 ;     700+ words ... ... results from its Phase 3 clinical trial of SILENOR([TM]) (doxepin ... product candidate, SILENOR([TM]) (doxepin ... Administration for SILENOR[TM] in the third ... and a Phase 2/3 clinical trial for nalmefene for ...

Article: Somaxon Pharmaceuticals to Announce Results of Initial Phase 3 ...
PR Newswire;  April 9, 2006 ;     690 words ... ... plans to issue results from its initial Phase 3 clinical trial of SILENOR(TM) (doxepin HCl) for the treatment of adults ... of insomnia. Nalmefene HCl is in a Phase 2/3 clinical trial for pathological gambling and in a pilot Phase 2 ...

Article: Somaxon Pharmaceuticals to Announce Results of Phase 3 ...
PR Newswire;  October 22, 2006 ;     637 words ... ... company plans to issue results from its Phase 3 clinical trial of SILENOR(TM) (doxepin HCl) for the treatment of transient ... of insomnia. Nalmefene HCl is in a Phase 2/3 clinical trial for pathological gambling and has completed a pilot ...

Article: Elderly insomniacs.(BIOTECH)(Somaxon Pharmaceuticals Inc. does ...
San Diego Business Journal;  October 3, 2005 ;     700+ words ... ... announced recently that it is beginning third phase clinical trials on Silenor, a drug meant for the treatment of insomnia. The trial will evaluate the safety and efficacy of Silenor over three months in elderly patients with primary chronic insomnia ...